KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Current Assets (2016 - 2025)

Historic Current Assets for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $300.3 million.

  • CareDx's Current Assets fell 1011.92% to $300.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.3 million, marking a year-over-year decrease of 1011.92%. This contributed to the annual value of $351.8 million for FY2024, which is 1215.09% up from last year.
  • CareDx's Current Assets amounted to $300.3 million in Q3 2025, which was down 1011.92% from $307.3 million recorded in Q2 2025.
  • CareDx's Current Assets' 5-year high stood at $444.7 million during Q3 2021, with a 5-year trough of $300.3 million in Q3 2025.
  • For the 5-year period, CareDx's Current Assets averaged around $368.8 million, with its median value being $360.8 million (2023).
  • In the last 5 years, CareDx's Current Assets skyrocketed by 56401.43% in 2021 and then crashed by 1911.47% in 2023.
  • Quarter analysis of 5 years shows CareDx's Current Assets stood at $433.4 million in 2021, then decreased by 10.5% to $387.8 million in 2022, then fell by 19.11% to $313.7 million in 2023, then grew by 12.15% to $351.8 million in 2024, then dropped by 14.65% to $300.3 million in 2025.
  • Its Current Assets stands at $300.3 million for Q3 2025, versus $307.3 million for Q2 2025 and $350.2 million for Q1 2025.